Preliminary Program subject to change
12B02 Best Practices in Process Development and Pilot Plants
OverviewThis session presents case studies, examples and strategies for optimization in process development and pilot plant activities.
Primary SponsorPilot Plants (12b)

Chair

Merril Galloway
Process Engineer
Sabic Americas, Inc.
SABIC Technology Center
1600 Industrial Blvd
Sugar Land, TX 77478
Phone Number: 281-207-5527
Email: mgalloway@americas.sabic.com

CoChair

Karl R. Krause
Experimental Station
Corporate Process Development
DuPont Engineering Research and Technology
PO Box 80249
Wilmington, DE 19880
Phone Number: 302-695-1524
Fax Number: 302-695-8689
Email: karl.r.krause@usa.dupont.com
Introductory Remarks
Leveraging Pilot Plants Through The Use Of Models
Salvador Aldrett, Reactive Hazards Assessment, Shell Global Solutions US, 3333 Highway 6 South, Room E-2061, Houston, TX 77082
Best Practices in Process Development of New Technology
Mary Ellen Yarossi, Independent Project Analysis, 44426 Atwater Drive, Ashburn, VA 20147
Operation Excellence in the Pilot - "Key Elements for Success"
Paula Clark, Process & Technology, Ciba Specialty Chemicals Corporation, 100 Ciba Road, McIntosh, AL 36553
Scaleup from Lab to Commercial in One Easy Step?
Mike J. Doll, HODer, Shell Global Solutions, 3333 Highway 6 South, Houston, TX 77082 and Jonathan H. Worstell, HODER, Shell Global Solutions US, 3333 Highway 6 South, Room E-2061, Houston, TX 77082
How to Design and Construct a Pilot Plant to Provide Maximum Value
Michael J. Zogg Jr.1, David A. Eversdyk1, Daniel C. Floyd1 and Pradeep Jain2, (1)Process Fundamentals, The Dow Chemical Company, 2301 N. Brazosport Blvd., Bldng. B-4001, Freeport, TX 77541-3257, (2)Process Fundamentals, The Dow Chemical Company, 2301 N. Brazosport Blvd., Bldng. B-1814, Freeport, TX 77541-3257
Thermal Cracking Studies By Design Of A Pilot Plant
Fatemeh Abniki, Process Eng.Dept. of National Petrochemical Company,Ghadir Group, Tehran, Iran and Ehsan Bakhshi, R&D Center of National Petrochemical Company, Tehran, Iran
Critical Process Parameter Determination for a Sterile Liquid Filled Syringe Product
John F. Peragine, Bristol-Myers Squibb Company, 1 Squibb Drive, Bldg. 137 rm 389, New Brunswick, NJ 08903
Concluding Remarks

Process Development Division